Author

Cecily A. Gibson

Howard Hughes Medical Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Assay:proteomics· 2 Organism:chicken / avian· 1 Assay:cryo-EM· 1 Research Focus:protein structure prediction· 1

Frequent Co-Authors

David VeesleriD· 3 shared Cameron StewartiD· 2 shared Young‐Jun ParkiD· 2 shared Alberto Ospina-Stella· 1 shared Alexander A. KhromykhiD· 1 shared Andrew Ginn· 1 shared Angelica L. Morgan· 1 shared Angelika Bröer· 1 shared

Activity by Year

2024-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 32 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

David VeeslerORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Proteolytic control of the SARS-CoV-2 furin cleavage site defines the phenotypic evolution from the pandemic to endemic state

Anupriya Aggarwal, Samantha Ognenovska, Timothy Ison, Christina Fichter, Vanessa Milogiannakis, Madeeha Afzal, Alberto Ospina-Stella, Daniel Asarnow, Angelica L. Morgan, Shafagh A. Waters, Till Böcking, Boaz Ng, Camille Esneau, Nathan Bartlett, Atharva Naik, , Stuart Grant Turville

The paper shows how SARS-CoV-2 variants, particularly Omicron, evolved proteolytic controls at the Spike furin cleavage site to enhance transmission while reducing lower respiratory tract pathogenicity.

bioRxiv · Sep 24, 2026 · PreprintMicrobiology

Pan-neutralization of parainfluenza viruses by a hemagglutinin-neuraminidase antibody

Anna De Marco, Risako Gen, Young‐Jun Park, Giuseppe Cusumano, Cecily A. Gibson, Siddhant Vyas, Corey Momont, Federico Tasin, Silvia Chiara Galli, Benjamin Merz, Isabella Giacchetto-Sasselli, Eneida Vetti, Tyson A. Rietz, Brian V. Tsu, Kevin C. Yim, , David Veesler

This paper identifies a monoclonal antibody, PVA269, that broadly neutralizes multiple parainfluenza viruses by targeting the HN glycoprotein, showing potent prophylactic activity in a cotton rat model.

bioRxiv · Sep 10, 2026 · PreprintImmunology

Molecular basis of pathogenicity of the recently emerged FCoV-23 coronavirus

M. Alejandra Tortorici, Annette Choi, Cecily A. Gibson, Jimin Lee, Jack T Brown, Cameron Stewart, Anshu Joshi, Sheri Harari, Isabelle Willoughby, Catherine Treichel, Elizabeth M. Leaf, Jesse D. Bloom, Neil P. King, Christine Tait‐Burkard, Gary R. Whittaker, David Veesler

This study identifies molecular mechanisms of FCoV-23 pathogenicity, including receptor usage and biotype switching, and identifies a cross-reactive antibody for therapeutic development.

bioRxiv · Aug 25, 2024 · PreprintBiochemistry